Efficacy of 101 antimicrobials and other agents on the development of Cryptosporidium parvum in vitro

REFERENCES

• Anderson, J., George, R. J. D., Weller, I. V. D., Lucas, C. B. & Miller, R. F. (1991). Complications of treatment for cryptosporidial diarrhea. Genitourinary Medicine, 67, 156–161.
   PubMedGoogle Scholar
• Angus, K. W., Hutchinson, G., Campbell, I. & Snodgrass, D. R. (1984). Prophylactic effects of anticoccidial drugs in experimental murine cryptosporidiosis. Veterinary Record, 114, 166–168.
   PubMed Web of Science ®Google Scholar
• Anon. (1982). Cryptosporidiosis: an assessment of chemotherapy in males with acquired immune deficiency syndrome (AIDS). Morbidity and Mortality Weekly Report, 31, 589–592.
   PubMedGoogle Scholar
• Anon. (1984). Update: treatment of cryptosporidiosis in patients with acquired immunodeficiency syndrome (AIDS). Morbidity and Mortality Weekly Report, 33, 117–119.
   PubMedGoogle Scholar
• Araujo, F. G., Prokocimer, P. & Remington, J. S. (1992). Clarithromycin-minocyline is synergistic in a murine model of toxoplasmosis. Journal of Infectious Diseases, 165 788.
   PubMed Web of Science ®Google Scholar
• Armitage, K., Flanigan, T., Carey, J., Frank, I., MacGregor, R. R., Ross, P., Goodgame, R. & Turner, J. (1992). Treatment of cryptosporidiosis with paromomycin. Report of five cases. Archives of Internal Medicine, 152, 2497–2499.
   PubMedGoogle Scholar
• Arrowood, M. J., Xie, L.-T. & Hurd, M. R. (1994). In vitro assays of maduracicin activity against Cryptosporidium parvum. Journal of Eukaryotic Microbiology, 41, 23s–24s.
   PubMed Web of Science ®Google Scholar
• Bissuel, F., Cotte, L., Rabodonirina, M., Rougier, P., Piens, M.-A. & Trepo, C. (1994). Paromomycin: an effective treatment for cryptosporidial diarrhea in patients with AIDS. Clinical Infectious Diseases, 18, 447–449.
   PubMed Web of Science ®Google Scholar
• Brasseur, P., Favennec, L., Lemeteil, D., Roussel, F. & Ballet, J. J. (1994). An immunosuppressed rat model for evaluation of anti-Cryptosporidium activity in sinefungin. Folia Parasitologica, 41, 13–16.
   PubMed Web of Science ®Google Scholar
• Brasseur, P., Lemeteil, D. & Ballet, J. J. (1991). Anti-cryptosporidial drug activity screened with an immunosuppressed rat model. Journal of Protozoology, 38, 230s–232s.
   PubMedGoogle Scholar
• Chiampi, N. P., Sudberg, R. D., Klompus, J. P. & Wilson, A. J. (1983). Cryptosporidial enteritis and Pneumocystis pneumonia in a homosexual man. Human Pathology, 14, 734–737.
   PubMed Web of Science ®Google Scholar
• Connolly, G. M., Dryden, M. S., Shanson, D. C. & Gazzard, B. G. (1988). Cryptosporidial diarrhea in AIDS and its treatment. Gut, 29, 593–597.
   PubMed Web of Science ®Google Scholar
• Denizot, F. & Lang, R. (1986). Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. Journal of Immunological Methods, 89, 271–277.
   PubMed Web of Science ®Google Scholar
• Dubey, J. P., Speer, C. A. & Fayer, R. (1990). Cryptosporidiosis of Man and Animal. Boca Ranton, FL: CRC Press.
   Google Scholar
• Favennec, L., Egraz-Bernard, M., Comby, E., Lemeteil, D., Ballet, J.-J. & Brasseur, P. (1994). Immunofluorescence detection of Cryptosporidium parvum in Caco-2 cells: a new screening method for anticryptosporidial activity. Journal of Eukaryotic Microbiology, 41, 39s.
   PubMed Web of Science ®Google Scholar
• Fayer, R. & Ellis, W. (1993a). Glycoside antibiotics alone and combined with tetracylines for prophylaxis of experimental cryptosporidiosis in neonatal BALB/c mice. Journal of Parasitology, 79, 553–558.
   PubMed Web of Science ®Google Scholar
• Fayer, R. & Ellis, W. (1993b). Paromomycin is effective as prophylaxis for cryptosporidiosis in dairy calves. Journal of Parasitology, 79, 771–774.
   PubMed Web of Science ®Google Scholar
• Fichetenbaum, C. J., Ritchie, D. J. & Powderly, W. G. (1993). Use of paromomycin for treatment of cryptosporidiosis in patients with AIDS. Clinical Infectious Diseases, 16, 298–300.
   PubMed Web of Science ®Google Scholar
• Forgacs, P., Tarshis, A., Ma, P., Federman, M., Mele, L., Silverman, M. L. & Shea, J. A. (1983). Intestinal and bronchial cryptosporidiosis in an immunodeficient homosexual man. Annals of Internal Medicine, 99, 793–794.
   PubMed Web of Science ®Google Scholar
• Goodstein, R. S., Columbo, C. S., Illfelder, M. A. & Skaggs, R. E. (1989). Bronchial and gastrointestinal cryptosporidiosis in AIDS. Journal of the American Osteopathic Association, 89, 195–197.
   PubMed Web of Science ®Google Scholar
• Healey, M. C., Yang, S., Rasmussen, K. R., Jackson, M. K. & Du, C. (1995). Therapeutic efficacy of paromomycin in immunosuppressed adult mice infected with Cryptosporidium parvum. Journal of Parasitology, 81, 114–116.
   PubMed Web of Science ®Google Scholar
• Iselt, M., Holtei, W. & Hilgard, P. (1989). The tetrazolium dye assay for rapid in vitro assessment of cytotoxicity. Arzneimittel Forschung, 39, 747–749.
   PubMed Web of Science ®Google Scholar
• Kim, C. W. (1987). Chemotherapeutic effect of arprinocid in experimental cryptosporidiosis. Journal of Parasitology, 73, 663–666.
   PubMed Web of Science ®Google Scholar
• Kimata, I., Uni, S. & Iseki, M. (1991). Chemotherapeutic effect of azithromycin and lasalocid on Cryptosporidium infection in mice. Journal of Protozoology, 38, 232s–233s.
   PubMedGoogle Scholar
• Leitch, G. J. & He, Q, (1994). Putative anticryptosporidial agents tested with an immunodeficient mouse model. Antimicrobial Agents and Chemotherapy, 38, 865–867.
   PubMed Web of Science ®Google Scholar
• Lemeteil, D., Roussel, F., Favennec, L., Ballet, J. J. & Brasseur, P. (1993). Assessment of candidate anticryptosporidial agents in an immunosuppressed rat model. Journal of Infectious Diseases, 167, 766–768.
   PubMed Web of Science ®Google Scholar
• Mancassola, R., Reperant, J.-M., Naciri, M. & Chartier, C. (1995). Chemoprophylaxis of Cryptosporidium parvum infection with paromomycin in kids and immunological study. Antimicrobial Agents and Chemotherapy, 39, 75–78.
   PubMed Web of Science ®Google Scholar
• McDonald, V., Stables, R., Warhurst, D. C., Barer, M. R., Blewett, D. A., Chapman, H. D., Connolly, G. M., Chiodini, P. L. & McAdam, K. P. W. J. (1990). In vitro cultivation of Cryptosporidium parvum and screening for anticryptosporidial drugs. Antimicrobial Agents and Chemotherapy, 34, 1498–1500.
   PubMed Web of Science ®Google Scholar
• Mead, J. R., You, X., Pharr, J. E., Belenkaya, Y., Arrowood, M. J., Fallon, M. T. & Schinazi, R. F. (1995). Evaluation of maduramicin and alborixin in a SCID mouse model of chronic cryptosporidiosis. Antimicrobial Agents and Chemotherapy, 39, 854–858.
   PubMed Web of Science ®Google Scholar
• Merli, A., Canessa, A. & Melioli, G. (1985). Enzyme immunoassay for evaluation of Toxoplasma gondii growth in tissue culture. Journal of Clinical Microbiology, 21, 88–91.
   PubMed Web of Science ®Google Scholar
• Mohri, H., Fujita, H., Asakura, Y., Katoh, K., Okamoto, R., Tanabe, J., Harano, J., Noguchi, T., Inayama, Y., Amano, T. & Okubo, T. (1995). Case report: therapy of paromomycin is effective for respiratory infection and hypoxia by Cryptosporidium with AIDS. American Journal of Medical Science, 309, 60–62.
   PubMed Web of Science ®Google Scholar
• Moon, H. W., Woode, G. N. & Ahrens, F. A. (1982). Attempted chemoprophylaxis of cryptosporidiosis in calves. Veterinary Record, 110, 181.
   PubMed Web of Science ®Google Scholar
• Naciri, M., Mancassola, R., Yvoré, P. & Peeters, J. E. (1993). The effect of halofuginone lactate on experimental Cryptosporidium parvum infections in calves. Veterinary Parasitology, 45, 199–207.
   PubMed Web of Science ®Google Scholar
• Navin, T. R. & Juranek, D. D. (1984). Cryptosporidiosis: clinical epidemiologic and parasitologic review. Reviews of Infectious Diseases, 6, 313–327.
   PubMedGoogle Scholar
• Nesterenko, M. V., Tilley, M. & Upton, S. J. (1995). A metallo-dependent cysteine proteinase of Cryptosporidium parvum associated with the surface of sporozoites. Microbios, 83, 77–88.
   PubMedGoogle Scholar
• Nesterenko, M. V. & Upton, S. J. (1996). A rapid microcentrifuge procedure for purification of Cryptosporidium sporozoites. Journal of Microbiological Methods, 25, 87–89.
   Web of Science ®Google Scholar
• Olson, J. A. (1990). In situ enzyme-linked immunosorbent assay to quantitate in vitro development of Eimeria tenella. Antimicrobial Agents and Chemotherapy, 34, 1435–1439.
   PubMed Web of Science ®Google Scholar
• Page, M., Behaoui, N., Clinq-Mars, B. & Lemieux, P. (1988). Optimization of the tetrazolium-based colorimetric assay for the measurement of cell number and cytotoxicity. International Journal of Immunopharmacology, 10, 785–793.
   PubMed Web of Science ®Google Scholar
• Pitlik, S. D., Fainstein, V., Garza, D., Guarda, L., Bolivar, R., Rios, A., Hopper, R. L. & Mansell, P. A. (1983). Human cryptosporidiosis: spectrum of disease. Report of six cases and review of the literature. Archives of Internal Medicine, 143, 2269–2275.
   PubMedGoogle Scholar
• Rasmussen, K. R., Arrowood, M. J. & Healey, M. C. (1992). Effectiveness of dehydroepiandrosterone in reduction of cryptosporidial activity in immunosuppressed rats. Antimicrobial Agents and Chemotherapy, 36, 220–222.
   PubMed Web of Science ®Google Scholar
• Rasmussen, K. R. & Healey, M. C. (1992). Dehydroepiandrosterone-induced reduction of Cryptosporidium parvum infections in aged Syrian golden hamsters. Journal of Parasitology, 78, 554–557.
   PubMed Web of Science ®Google Scholar
• Rasmussen, K. R., Healey, M. C., Cheng, L. & Yang, S. (1995). Effects of dehydroepiandrosterone in immunosuppressed adult mice infected with Cryptosporidium parvum. Journal of Parasitology, 81, 429–433.
   PubMed Web of Science ®Google Scholar
• Rasmussen, K. R., Martin, E. G., Arrowood, M. J. & Healey, M. C. (1991). Effects of dexamethasone and dehydroepiandrosterone in immunosuppressed rats infected with Cryptosporidium parvum. Journal of Protozoology, 38, 157s–159s.
   PubMedGoogle Scholar
• Rasmussen, K. R., Martin, E. G. & Healey, M. C. (1993). Effects of dehydroepiandrosterone in immunosuppressed rats infected with Cryptosporidium parvum. Journal of Parasitology, 79, 364–370.
   PubMed Web of Science ®Google Scholar
• Rehg, J. E. (1991a). Anticryptosporidial activity is associated with specific sulfonamides in immunosuppressed rats. Journal of Parasitology, 77, 238–240.
   PubMed Web of Science ®Google Scholar
• Rehg, J. E. (1991b). Anti-cryptosporidial activity of macrolides in immunosuppressed rats. Journal of Protozoology, 38, 228s–229s.
   PubMedGoogle Scholar
• Rehg, J. E. (1991c). Activity of azithromycin against Cryptosporidia in immunosuppressed rats. Journal of Infectious Diseases, 163, 1293–1296.
   PubMed Web of Science ®Google Scholar
• Rehg, J. E. (1993). Anticryptosporidial activity of lasalocid and other ionophorous antibiotics in immunosuppressed rats. Journal of Infectious Diseases, 168, 1566–1569.
   PubMed Web of Science ®Google Scholar
• Rehg, J. E. (1994). A comparison of anticryptosporidial activity of paromomycin with that of other aminoglycosides and azithromycin in immunosuppressed rats. Journal of Infectious Diseases, 170, 934–938.
   PubMed Web of Science ®Google Scholar
• Rehg, J. E. (1995). The activity of halofuginone in immunosuppressed rats infected with Cryptosporidium parvum. Journal of Antimicrobial Chemotherapy, 35, 391–397.
   PubMed Web of Science ®Google Scholar
• Rehg, J. E. & Hancock, M. L. (1990). Effectiveness of arprinocid in the reduction of cryptosporidial activity in immunosuppressed rats. American Journal of Veterinary Research, 51, 1668–1670.
   PubMed Web of Science ®Google Scholar
• Rehg, J. E., Hancock, M. L. & Woodmansee, D. B. (1988). Anticryptosporidial activity of sulfadimethoxine. Antimicrobial Agents and Chemotherapy, 32, 1907–1908.
   PubMed Web of Science ®Google Scholar
• Scaglia, M., Atzori, C., Marchetti, G., Orso, M., Maserati, R., Orani, A., Novati, S. & Olliaro, P. (1994). Effectiveness of aminosidine (paromomycin) sulfate in chronic Cryptosporidium diarrhea in AIDS patients: an open, uncontrolled, prospective clinical trial. Journal of Infectious Diseases, 170, 1349–1350.
   PubMed Web of Science ®Google Scholar
• Scudiero, D. A., Shoemaker, R. H., Paull, K. D., Monks, A., Tierney, S., Nofziger, T. H., Currens, M. J., Seniff, D. & Boyd, M. R. (1988). Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Research, 48, 4827–4833.
   PubMed Web of Science ®Google Scholar
• Sloper, K. S., Dourmashkin, R. R., Bird, R. B., Slavin, G. & Webster, A. D. B. (1982). Chronic malabsorption due to cryptosporidiosis in a child with immunoglobulin deficiency. Gut, 23, 80–82.
   PubMed Web of Science ®Google Scholar
• Sterling, C. R. & Arrowood, M. J. (1993). Cryptosporidia. In Parasitic Protozoa. Vol. 3, 2nd Edn, ed. Kreier, J. P. pp. 59–225. New York: Academic Press.
   Google Scholar
• Taghi-Kilani, R. & Sekla, L. (1987). Purification of Cryptosporidium parvum oocysts and sporozoites by cesium chloride and percoll gradients. American Journal of Tropical Medicine and Hygiene, 36, 505–508.
   PubMed Web of Science ®Google Scholar
• Upton, S. J., Tilley, M. & Brillhart, D. B. (1995). Effects of select medium supplements on in vitro development of Cryptosporidium parvum in HCT-8 cells. Journal of Clinical Microbiology, 33, 371–375.
   PubMed Web of Science ®Google Scholar
• Upton, S. J., Tilley, Ml, Nesterenko, M. V. & Brillhart, D. B. (1994). A simple and reliable method of producing in vitro infections of Cryptosporidium parvum (Apicomplexa). FEMS Microbiology Letters, 118, 45–50.
   PubMed Web of Science ®Google Scholar
• Vargas, S. L., Shenep, J. L., Flynn, P. M., Pui, C. H., Santana, V. M. & Hughes, W. T. (1993). Azithromycin for treatment of severe Cryptosporidium diarrhea in two children with cancer. Journal of Pediatrics, 123, 154–156.
   PubMed Web of Science ®Google Scholar
• Verdon, R., Polianski, J., Gaudebout, C., Marche, C., Garry, L. & Pocidalo, J.-J. (1994). Evaluation of curative anticryptosporidial activity of paromomycin in a dexamethansone-treated rat model. Antimicrobial Agents and Chemotherapy, 38, 1681–1682.
   PubMed Web of Science ®Google Scholar
• Wang, C. C., Simashkevich, P. M. & Stotish, R. L. (1979). Mode of anticoccidial action of arprinocid. Biochemical Pharmacology, 28, 2241–2248.
   PubMed Web of Science ®Google Scholar
• Weinstein, L., Edelstein, S. M., Madara, J. L., Falchuk, K. R., McManus, B. M. & Trier, J. S. (1981). Intestinal cryptosporidiosis complicated by disseminated cytomegalovirus infection. Gastroenterology, 81, 584–591.
   PubMed Web of Science ®Google Scholar
• White, A. C., Chappell, C. L., Hayat, C. S., Kimball, K. T., Flanigan, T. P. & Goodgame, R. W. (1994). Paromomycin for cryptosporidiosis in AIDS: a prospective, double-blind trial. Journal of Infectious Diseases, 170, 419–424.
   PubMed Web of Science ®Google Scholar
• Woods, K. M., Nesterenko, M. V. & Upton, S. J. (1995). Development of a microtitre ELISA to quantify development of Cryptosporidium parvum in vitro. FEMS Microbiology Letters, 128, 89–93.
   PubMed Web of Science ®Google Scholar